Hycult Biotech

Executive Summary

Hycult Biotech is a Netherlands-based private company founded in 1994, specializing in high-quality research reagents for innate immunity and complement system research. Its product portfolio includes antibodies, immunoassays (ELISA), proteins, and peptides, serving academic and industrial researchers worldwide. The company differentiates itself through deep expertise in the complement system, a niche but critical area for drug development and disease understanding. With a mission to accelerate research in immunology and inflammation, Hycult Biotech has built a loyal customer base and a reputation for reliable, specialized reagents. As a private entity, it focuses on steady growth and customer support rather than aggressive expansion. The company's long-standing presence and technical expertise position it as a key supplier in the innate immunity research space.

Upcoming Catalysts (preview)

• TBDExpansion of complement pathway-specific ELISA kits65% success
• TBDStrategic partnership with a major pharmaceutical company for custom antibody development50% success
• TBDLaunch of monoclonal antibodies for novel immune checkpoint targets40% success